Bayer Will Buy Merck Purchaser Device For $14.2 Billion

November 11, 2019 7:24 am Veröffentlicht von Schreibe einen Kommentar

German drug firm Bayer has agreed to acquire the buyer treatment small busine s of U.S.-based Merck & Co., in a deal Jordan Phillips Jersey that would bolster Bayer in the over-the-counter drug sector. The $14.2 billion purchase includes brands such as Claritin, Coppertone and Dr. Scholl’s. From Reuters:“The transaction, the largest in the German healthcare industry since Bayer bought rival Schering in 2006, will make Bayer the second biggest over-the-counter drugs maker after Johnson & Johnson, as it seeks to make better use of its distribution network and sales force.“Bayer says the deal with Merck, which is based mostly in New Jersey, will make it „the OTC leader in North America and Latin America.“ The two pharmaceutical companies are also agreeing to collaborate in „a cla s of drugs that includes Bayer’s Adempas, which is approved to treat a deadly lung disease,“ Bloomberg reports. Merck will pay Bayer $1 billion to get that venture started. The Bayer deal is being announced weeks after the news that „Swi s drugmaker Novartis is Marcus Murphy Jersey buying British corporation GlaxoSmithKline’s cancer drug busine s enterprise for up to $16 billion,“ as NPR’s Here & Now reported. That deal also includes a joint venture in the buyer drug sector.

Stichwörter: , , , , , ,

Kategorisiert in:

Dieser Artikel wurde verfasst von Don Waldhof